Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$483K Buy
1,372
+100
+8% +$35.6K 0.11% 164
2025
Q4
$416K Sell
1,272
-22
-2% -$6.98K 0.1% 169
2025
Q3
$365K Buy
1,294
+74
+6% +$21.5K 0.09% 174
2025
Q2
$341K Buy
1,220
+22
+2% +$6.23K 0.09% 179
2025
Q1
$373K Buy
1,198
+19
+2% +$5.61K 0.11% 163
2024
Q4
$307K Sell
1,179
-17
-1% -$5.04K 0.09% 183
2024
Q3
$385K Sell
1,196
-99
-8% -$32.4K 0.11% 167
2024
Q2
$405K Buy
1,295
+133
+11% +$39.1K 0.12% 156
2024
Q1
$330K Buy
1,162
+48
+4% +$14K 0.1% 168
2023
Q4
$321K Buy
1,114
+329
+42% +$89.6K 0.11% 167
2023
Q3
$211K Buy
+785
New +$196K 0.08% 196

Other funds holding AMGN

Old Port Advisors's AMGN Position: Q1 2026 in Review

Old Port Advisors increased its Amgen (AMGN) stake by 7.9% in Q1 2026, buying an estimated $35.6K and bringing the position to 1,372 shares worth $483K. The position accounts for 0.11% of the portfolio, ranked #164.

Old Port Advisors first reported a position in AMGN in Q3 2023 and has held it in 11 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Old Port Advisors held 1,372 shares of Amgen worth $483K as of Q1 2026.
  • Old Port Advisors bought 100 Amgen shares in Q1 2026, an estimated $35.6K.
  • Amgen made up 0.11% of Old Port Advisors's portfolio in Q1 2026, its #164 holding.
  • Old Port Advisors first reported a position in Amgen in Q3 2023 and has held it in 11 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Old Port Advisors's 13F filing for Q1 2026, filed 6 Apr 2026.